# 248. Are GLP-1s a Catalyst or a Crutch?

Page: https://stenobird.com/podcast/make-fit-simple-1367946/248-are-glp-1s-a-catalyst-or-a-crutch
Text version: https://stenobird.com/podcast/make-fit-simple-1367946/248-are-glp-1s-a-catalyst-or-a-crutch.md
Podcast: [Make Fit Simple](https://stenobird.com/podcast/make-fit-simple-1367946)
Published: 2025-08-20T09:00:00+00:00
Episode link: https://verifi.podscribe.com/rss/p/www.buzzsprout.com/1778813/episodes/17686292-248-are-glp-1s-a-catalyst-or-a-crutch.mp3
Audio file: https://verifi.podscribe.com/rss/p/www.buzzsprout.com/1778813/episodes/17686292-248-are-glp-1s-a-catalyst-or-a-crutch.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/make-fit-simple-1367946/episodes/248-are-glp-1s-a-catalyst-or-a-crutch
Duration seconds: 2006

## Resource

Andrea dives into a topic she’s been closely following for a long time: GLP-1 medications like Ozempic, Wegovy, and Mounjaro. As a personal trainer and nutrition coach, she breaks down what GLP-1s are, how they work, their benefits and side effects, and most importantly, whether they serve as a catalyst or a crutch in someone’s health journey. Drawing from real-life scenarios, client experiences, and extensive research, Andrea brings a clear, thoughtful perspective to a complex and often cont...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/make-fit-simple-1367946/episodes/248-are-glp-1s-a-catalyst-or-a-crutch/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/make-fit-simple-1367946/248-are-glp-1s-a-catalyst-or-a-crutch.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.